The 9.4% return this week takes Aclaris Therapeutics’ (NASDAQ:ACRS) shareholders one-year gains to 510%
Some Aclaris Therapeutics, Inc. (NASDAQ:ACRS) shareholders are probably rather concerned to see the share price fall 30% over the last three months. But that isn’t a problem when you consider how the share price has soared over the last year. In that time,…
